galanin-like-peptide and Edema

galanin-like-peptide has been researched along with Edema* in 2 studies

Other Studies

2 other study(ies) available for galanin-like-peptide and Edema

ArticleYear
Galanin-like peptides exert potent vasoactive functions in vivo.
    The Journal of investigative dermatology, 2007, Volume: 127, Issue:3

    The cutaneous vasculature plays a key role in the pathophysiology of inflammatory skin diseases. The vascular activity is under the control of the peripheral nervous system that includes locally released neuropeptides. Recently, we detected receptors for the neuropeptide galanin in association with dermal blood vessels, suggesting a role of the galanin-peptide-family in the regulation of the cutaneous microvasculature. Therefore, we have investigated galanin and galanin-like peptide (GALP), a neuropeptide previously only considered to be involved in metabolism and reproduction in the central nervous system, for vaso-modulatory activity in the murine skin in vivo. Picomole amounts of intradermally injected galanin and GALP decreased cutaneous blood flow and inhibited inflammatory edema formation. Both the full-length GALP (1-60) and the putative smaller proteolytic fragment GALP (3-32) showed similar effects. These activities are most likely mediated by galanin receptors galanin receptor subtype 2 (GalR2) and/or galanin receptor subtype 3 (GalR3), because reverse transcription-PCR analysis of murine skin revealed messenger RNA (mRNA) expression of GalR2 and GalR3 but not of galanin receptor subtype 1. The lack of galanin receptor mRNAs in endothelial and smooth muscle cells indicates a neuronal localization of these receptors around the vessels. These results indicate functional activity of GALP in the periphery in vivo and suggest a potential role as an inflammatory modulator.

    Topics: Animals; Blood Vessels; Calcitonin Gene-Related Peptide; Edema; Endothelial Cells; Female; Galanin; Galanin-Like Peptide; Inflammation; Mice; Neuropeptides; Peptides; RNA, Messenger; Skin; Vasodilator Agents

2007
Alarin is a vasoactive peptide.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Jun-12, Volume: 104, Issue:24

    Galanin-like peptide (GALP) is a hypothalamic neuropeptide belonging to the galanin family of peptides. The GALP gene is characterized by extensive differential splicing in a variety of murine tissues. One splice variant excludes exon 3 and results in a frame shift leading to a novel peptide sequence and a stop codon after 49 aa. In this peptide, which we termed alarin, the signal sequence of the GALP precursor peptide and the first 5 aa of the mature GALP are followed by 20 aa without homology to any other murine protein. Alarin mRNA was detected in murine brain, thymus, and skin. In accordance with its vascular localization, the peptide exhibited potent and dose-dependent vasoconstrictor and anti-edema activity in the cutaneous microvasculature, as was also observed with other members of the galanin peptide family. However, in contrast to galanin peptides in general, the physiological effects of alarin do not appear to be mediated via the known galanin receptors. Alarin adds another facet to the surprisingly high-functional redundancy of the galanin family of peptides.

    Topics: Amino Acid Sequence; Animals; Dermis; Dose-Response Relationship, Drug; Edema; Female; Frameshift Mutation; Galanin-Like Peptide; Humans; Hypothalamus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Molecular Sequence Data; Peptides; Protein Sorting Signals; Regional Blood Flow; RNA Splicing; RNA, Messenger; Skin; Tissue Distribution; Vasodilator Agents

2007